Literature DB >> 2865160

Peripheral dopamine receptor blockade by SCH 23390 and domperidone in vitro.

A Hilditch, G M Drew.   

Abstract

The antagonist potencies of SCH 23390 and domperidone have been determined at vascular and neuronal dopamine receptors in the rabbit isolated splenic artery and rectococcygeus muscle, respectively. SCH 23390 was a potent, competitive antagonist at vascular (pA2 = 10.65) but not neuronal (pA2 less than 6.0) receptors. Domperidone was a potent, competitive antagonist at neuronal (pA2 = 7.9) but not vascular (pA2 less than 4.0) receptors. SCH 23390 and domperidone are, therefore, highly selective vascular and neuronal dopamine receptor antagonists respectively.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865160     DOI: 10.1016/0014-2999(85)90199-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Proceedings of the British Pharmacological Society. Amsterdam, 2nd-4th July 1986. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

2.  Proceedings of the British Pharmacological Society. 17th-19th December 1986. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

3.  Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.

Authors:  A G Dupont; R A Lefebvre; P Vanderniepen
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

4.  The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries.

Authors:  A D Hughes; P S Sever
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

5.  Potentiation of the effects of dopamine in the rabbit isolated splenic artery by 3-isobutyl-1-methylxanthine or forskolin.

Authors:  K L Clark; G M Drew; A Hilditch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

6.  The neuropharmacology of (-)-stepholidine and its potential applications.

Authors:  Kechun Yang; Guozhang Jin; Jie Wu
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.